Cite
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
MLA
Delaunay, Tiphaine, et al. “Oncolytic Viruses Sensitize Human Tumor Cells for NY-ESO-1 Tumor Antigen Recognition by CD4+ Effector T Cells.” OncoImmunology, vol. 7, no. 3, Mar. 2018, pp. 1–13. EBSCOhost, https://doi.org/10.1080/2162402X.2017.1407897.
APA
Delaunay, T., Violland, M., Boisgerault, N., Dutoit, S., Vignard, V., Mănz, C., Gannage, M., Dréno, B., Vaivode, K., Pjanova, D., Labarriére, N., Wang, Y., Antonio Chiocca, E., Boeuf, F. L., Bell, J. C., Erbs, P., Tangy, F., Grégoire, M., & Fonteneau, J.-F. (2018). Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells. OncoImmunology, 7(3), 1–13. https://doi.org/10.1080/2162402X.2017.1407897
Chicago
Delaunay, Tiphaine, Mathilde Violland, Nicolas Boisgerault, Soizic Dutoit, Virginie Vignard, Christian Mănz, Monique Gannage, et al. 2018. “Oncolytic Viruses Sensitize Human Tumor Cells for NY-ESO-1 Tumor Antigen Recognition by CD4+ Effector T Cells.” OncoImmunology 7 (3): 1–13. doi:10.1080/2162402X.2017.1407897.